SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+14.5%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$462M
AUM Growth
+$462M
(+45%)
Cap. Flow
+$154M
Cap. Flow
% of AUM
33.42%
Top 10 Holdings %
Top 10 Hldgs %
38.37%
Holding
96
New
33
Increased
16
Reduced
11
Closed
16
Top Buys
| 1 |
Nice
NICE
|
$26.4M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$18M |
| 3 |
Microsoft
MSFT
|
$15.7M |
| 4 |
Nutrien
NTR
|
$10.7M |
| 5 |
BridgeBio Pharma
BBIO
|
$9.32M |
Top Sells
| 1 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$10M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$9.46M |
| 3 |
AstraZeneca
AZN
|
$7.98M |
| 4 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$6.51M |
| 5 |
FIVE9
FIVN
|
$6.45M |
Sector Composition
| 1 | Healthcare | 77.13% |
| 2 | Technology | 11.54% |
| 3 | Materials | 2.33% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Utilities | 1.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sanofi
SNY
$121B
| $28.8M | 4.82% | 529,515 -30,000 | -5% | -$1.63M |
|
|
2
Nice
NICE
$8.73B
| $26.4M | 4.42% | +115,482 | New | +$26.4M |
|
|
3
AstraZeneca
AZN
$248B
| $19.8M | 3.31% | 285,060 -115,000 | -29% | -$7.98M |
|
4
Johnson & Johnson
JNJ
$427B
| $18.6M | 3.1% | 119,831 +10,000 | +9% | +$1.55M |
|
|
5
Teva Pharmaceuticals
TEVA
$21.1B
| $18M | 3.02% | +2,039,500 | New | +$18M |
|
|
6
Microsoft
MSFT
$3.77T
| $15.7M | 2.63% | +54,623 | New | +$15.7M |
|
7
Syndax Pharmaceuticals
SNDX
$1.41B
| $14.4M | 2.41% | 683,061 -27,500 | -4% | -$581K |
|
8
Merck
MRK
$210B
| $12.8M | 2.14% | 120,600 | – | – |
|
9
Novo Nordisk
NVO
$251B
| $11.4M | 1.9% | 71,540 | – | – |
|
10
Eli Lilly
LLY
$657B
| $10.9M | 1.82% | 31,690 +6,000 | +23% | +$2.06M |
|
|
11
Nutrien
NTR
$28B
| $10.7M | 1.8% | +145,466 | New | +$10.7M |
|
|
INZY
12
DELISTED
Inozyme Pharma
INZY
| $10.2M | 1.71% | 1,781,858 +156,800 | +10% | +$898K |
|
13
AbbVie
ABBV
$372B
| $10M | 1.68% | 63,000 +3,000 | +5% | +$478K |
|
14
Biogen
BIIB
$19.4B
| $9.32M | 1.56% | 33,516 +26,000 | +346% | +$7.23M |
|
|
15
BridgeBio Pharma
BBIO
$9.89B
| $9.32M | 1.56% | +561,983 | New | +$9.32M |
|
16
Amazon
AMZN
$2.44T
| $8.85M | 1.48% | +85,680 | New | +$8.85M |
|
17
Invesco QQQ Trust
QQQ
$364B
| $8.46M | 1.41% | +26,353 | New | +$8.46M |
|
|
SWTX
18
DELISTED
SpringWorks Therapeutics
SWTX
| $8.18M | 1.37% | 317,625 +1,000 | +0.3% | +$25.7K |
|
19
PTC Therapeutics
PTCT
$3.92B
| $7.71M | 1.29% | +159,100 | New | +$7.71M |
|
20
Enlight Renewable Energy
ENLT
$3.36B
| $7.63M | 1.27% | +450,864 | New | +$7.63M |
|
21
Kura Oncology
KURA
$686M
| $7.38M | 1.23% | 603,287 +45,000 | +8% | +$550K |
|
22
Ultragenyx Pharmaceutical
RARE
$2.89B
| $7.37M | 1.23% | 183,696 | – | – |
|
23
Jasper Therapeutics
JSPR
$45.5M
| $7.32M | 1.22% | +4,044,008 | New | +$7.32M |
|
|
PNT
24
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $6.93M | 1.16% | 952,642 | – | – |
|
25
Camtek
CAMT
$3.78B
| $6.79M | 1.13% | 239,494 +129,494 | +118% | +$3.67M |
|